330440001: Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing immunomodulator (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Product containing neomycin in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by disposition (product)\Product containing hormone (product)\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing steroid (product)\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing neomycin (medicinal product)\Product containing neomycin in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone and neomycin only product\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Medicinal product categorized by structure\Product containing glycoside (product)\Product containing aminoglycoside (product)\Product containing neomycin (medicinal product)\Product containing betamethasone and neomycin (medicinal product)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

\Product manufactured as ocular dose form (product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)
\Product manufactured as ocular dose form (product)\Product containing neomycin in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3692832010 Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692834011 Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4736381000005115 betamethasondinatriumphosphat 0,1 % + neomycinsulfat 0,5 % øjensalve da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Betamethasone+neomycin sulfate	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	diverse øjenpræparater	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Betamethasone	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Adrenal hormone	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	neomycin til topikal anvendelse	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	betamethason til topikal anvendelse	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Betamethasone sodium phosphate	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Corticosterone	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Neomycin sulfate	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Antiinfektiøst middel til huden	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	binyrehormonmiddel	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	glucocorticoidhormon	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Baktericid	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Local anti-infective	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	betamethason til oftalmisk anvendelse	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing neomycin in ophthalmic dosage form	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has manufactured dose form	Eye ointment	true	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing betamethasone and neomycin (medicinal product)	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Count of base of active ingredient	to	false	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength numerator value	fem	false	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength numerator value	en	false	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Betamethasone sodium phosphate	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Neomycin sulfate	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute specifies the denominator unit for the concentration strength of a product.	g	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Betamethasone sodium phosphate	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator value	en	false	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Neomycin sulfate	true	Inferred relationship	Some	2
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute specifies the numerator unit for the concentration strength of a product.	mg	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Has concentration strength denominator value	en	false	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute specifies the denominator unit for the concentration strength of a product.	g	true	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Is a	Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)	true	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	Plays role	Antibacterial therapeutic role (role)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3692832010	Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692834011	Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4736381000005115	betamethasondinatriumphosphat 0,1 % + neomycinsulfat 0,5 % øjensalve	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)